While upstream-targeted strategies focus on the β-globin gene cluster expression, namely the Hb switching mechanism, downstream-targeted approaches address the multitude of pathophysiological mechanisms of SCD. The gene discussed is GSTM1; the disease is Schnyder corneal dystrophy.